Microvision, Inc.

MVIS Technology Scientific & Technical Instruments

Microvision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, down 74.3% from fiscal 2024. In the quarter to June 2026, revenue grew 850.3%, EPS fell 84.5%, free cash flow fell 50.3% and total debt fell 43.3%, each against the same quarter a year earlier.

1.15 0.08 −6.50%
Market cap
$37.6M
P/E
0.0×
Fwd P/E
−5.0×
Dividend yield
—
F-score
3/9
Altman Z
−12.18
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
3 1 3 2 5 3 2 3 2 6
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
187.76 58.47 65.26 327.73 312.38 243.58 9.02 2.97 12.40 4.54
Altman Z-Score
(12.18) (9.62) (1.23) 0.25 20.78 (2.99) (71.99) (34.70) (23.12) (33.06)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(31.19) (25.26) (17.53) (14.23) (5.86) (92.19) (176.67) (85.16) (61.13) (82.63)
P/Operating CF
(14.72) (18.24) (28.57) (47.62) (98.70) (178.02) (18.60) (16.79) (15.65) (16.92)
Beneish M-Score
— — — — — — 4.54 11.75 — (3.32)
P/B ratio
4.08 5.63 4.94 4.46 7.14 83.55 0.00 12.68 11.84 8.97
Price to Tangible BV
4.09 7.27 6.03 4.46 7.15 85.09 0.00 14.38 12.59 9.93
EV/Sales
125.43 44.38 56.44 271.33 267.79 238.65 8.44 2.19 10.64 3.52
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(2.58) (3.04) (6.11) (8.71) (23.48) (45.87) (3.12) (1.70) (6.62) (3.50)
EV/FCF
(2.55) (3.02) (5.94) (7.82) (21.64) (46.23) (3.03) (1.62) (5.53) (3.30)
Quick Ratio
2.50 1.65 3.80 7.24 9.26 1.68 0.48 0.78 0.89 2.12
Current Ratio
2.69 1.79 4.23 7.97 9.58 1.75 0.54 0.97 1.22 2.39
Net Debt/EBITDA
1.38 0.95 0.95 1.33 2.71 1.20 0.21 0.54 0.70 1.00
Debt/Assets
0.03% 7.23% 0.00% 12.03% 0.32% 7.74% 5.83% 0.23% 0.00% 0.00%
Debt/Equity
0.00 0.18 0.00 0.15 0.00 0.18 (0.17) 0.01 0.00 0.00
Asset Turnover
0.01 0.04 0.06 0.01 0.03 0.19 0.51 0.67 0.39 0.86
Operating CF/Net income
0.62 0.71 0.81 0.72 0.68 1.18 0.91 0.83 0.61 0.90
Capex/Depreciation
(0.02) (0.02) (0.25) (1.94) (1.70) 0.13 (0.41) (0.61) (2.42) (0.71)
Interest Coverage
(4.47) (19.19) (1,110.94) (869.19) — — — — — —
ROE
(182.10%) (134.07%) (89.30%) (52.44%) (70.96%) (541.90%) (37,886.98%) (383.73%) (290.28%) (449.99%)
ROA
(84.70%) (77.29%) (67.73%) (43.30%) (57.13%) (83.03%) (151.90%) (103.22%) (102.20%) (96.47%)
ROIC
0.00% 0.00% (296.04%) (161.46%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(171.93%) (222.38%) (110.04%) (61.44%) (39.27%) (144.81%) 555.20% (1,110.43%) (344.68%) (141.50%)
Average Days of Receivables
14.20 71.97 47.72 0.00 0.00 0.00 44.32 9.87 0.57 6.06
Research and Development Expense of Revenue
2,625.83% 1,043.76% 781.20% 4,580.27% 964.44% 318.45% 210.00% 140.09% 156.70% 82.20%
Selling, General and Administrative Expense of Revenue
1,682.53% 624.91% 505.43% 3,620.63% 890.24% 191.49% 91.53% 54.09% 105.42% 59.23%
Intangible Assets out of Total Assets
0.00 0.09 0.13 0.00 0.00 0.01 0.02 0.02 0.02 0.04
Share Based Compensation of Revenue
58.03% 245.63% 222.36% 2,328.46% 611.36% 41.97% 18.16% 6.03% 13.37% 8.29%
Graham Net Nets
0.15 0.04 0.11 0.16 0.13 0.01 (0.10) (0.02) 0.03 0.07
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 6.59 0.00 0.00 0.00
Earnings Yield
(42.15%) (34.33%) (17.37%) (13.27%) (4.70%) (1.86%) (33.32%) (52.79%) (20.11%) (24.02%)
Free Cash Flow Yield
(26.19%) (25.10%) (14.57%) (10.59%) (3.96%) (2.12%) (30.92%) (45.37%) (15.51%) (23.43%)
Revenue per Share
0.07 0.34 0.60 0.06 0.23 0.33 1.20 3.03 1.98 4.26
Operating CF per Share
(3.22) (4.90) (5.50) (3.43) (2.74) (1.72) (3.24) (3.89) (3.19) (4.28)
Capex per Share
(0.04) (0.03) (0.16) (0.39) (0.23) 0.01 (0.10) (0.19) (0.63) (0.26)
Free Cash Flow per Share
(3.26) (4.93) (5.66) (3.83) (2.98) (1.71) (3.34) (4.08) (3.81) (4.53)
Cash per Share
4.13 5.36 6.32 7.47 10.77 1.81 0.79 2.37 3.49 4.37
Shareholders Equity per Share
3.05 3.49 7.86 8.11 10.52 0.97 (0.54) 0.71 2.08 2.16
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
3.05 3.49 7.86 8.11 10.52 0.97 (0.54) 0.71 2.08 2.16
Free Cash Flow
(59.40) (68.91) (69.02) (42.38) (31.90) (15.95) (24.79) (23.69) (18.52) (15.71)
Working Capital
50.96 36.52 66.25 79.58 106.97 7.53 (6.62) (0.54) 4.14 10.10
Capital Expenditures
(0.68) (0.37) (1.93) (4.36) (2.49) 0.12 (0.74) (1.12) (3.04) (0.89)
Net Current Asset Value
33.54 10.08 52.92 65.75 101.96 5.56 (7.98) (1.27) 3.54 4.72
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.56 0.08 0.27 6.56 1.00 (0.04) 0.08 0.06 0.32 0.06
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
6.60 2.25 0.87 0.33 0.48 0.51 0.98 0.61 0.39 0.81
Cash ROIC
(45.38%) (52.02%) (39.93%) (22.75%) (13.96%) (58.01%) (972.08%) (132.07%) (68.46%) (69.48%)
Accounts Receivable Turnover
2.48 5.01 7.16 0.00 0.00 0.00 11.43 71.72 74.11 15.28
Accounts Payable Turnover
13.44 4.43 1.28 0.04 0.00 1.12 4.00 3.89 3.75 4.74
Inventory Turnover
12.21 2.44 0.97 0.05 0.00 12.94 13.17 3.77 3.42 9.90
Average Days of Payables
32.04 54.87 299.03 7,522.65 654,080.00 164.49 79.74 82.72 113.36 77.23
Days of Inventory on Hand
14.66 111.20 510.10 6,792.65 324,850.00 6.27 8.18 38.05 168.07 43.38
Average Receivables
0.49 0.94 1.01 — — — 0.78 0.25 0.13 0.97
Average Payables
1.38 1.70 2.17 2.82 2.11 1.25 2.14 2.74 2.63 2.19
Average Inventory
1.52 3.08 2.87 1.82 0.90 0.11 0.65 2.83 2.89 1.05
Average Assets
112.14 125.40 122.32 122.61 75.62 16.42 17.43 26.40 24.94 17.07
Average Common Equity
52.16 72.29 92.77 101.25 60.88 2.52 0.07 7.10 8.78 3.66

Fold the line items

Columns are period end dates